Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cells

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 6, 2013, Pages 719-728

  Berglin, Lena ^a   Björkström, Niklas K ^a   Bergquist, Annika ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoantibodies; Biliary epithelial cells; IgA; Primary sclerosing cholangitis

Indexed keywords

IMMUNOGLOBULIN A;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CONTROLLED STUDY; DISEASE DURATION; ENTERITIS; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ANTIGENS, THY-1; AUTOANTIBODIES; CALCIUM-BINDING PROTEINS; CALMODULIN-BINDING PROTEINS; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CELLS, CULTURED; CHOLANGITIS, SCLEROSING; DISEASE PROGRESSION; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIVER; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED;

EID: 84878440351     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.786131     Document Type: Article

References (27)

1. Mendes F, Lindor KD. Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol 2010;7:611-19.
2. Broomé U, Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis 2006;26:31-41.
3. Karlsen TH, Kaser A. Deciphering the genetic predisposition to primary sclerosing cholangitis. Semin Liver Dis 2011;31: 188-207.
4. Hov J, Boberg KM, Karlsen TH. Autoantibodies in primary sclerosing cholangitis. WJG 2008;14:3781-91.
5. Mandal A, Dasgupta A, Jeffers L, Squillante L, Hyder S, Reddy R, et al. Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology 1994;106:185-92.
6. Xu B, Broome U, Ericzon B, Sumitran-Holgersson S. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6. Gut 2002;51:120-7.
7. Woof JM, Russell MW. Structure and function relationships in IgA. Mucosal Immunol 2011;4:590-7.
8. Monteiro RC. Role of IgA and IgA fc receptors in inflammation. J Clin Immunol 2010;30:1-9.
9. Woof JM, Kerr MA. The function of immunoglobulin A in immunity. J Pathol 2006;208:270-82.
10. Chen XM, O'Hara SP, LaRusso NF. The immunobiology of cholangiocytes. Immunol Cell Biol 2008;86:497-505.
11. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006;43:S54-62.
12. Robertson H, Kirby J, Yip W, Jones DE, Burt A. Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology 2007;45:977-81.
13. Omenetti A, Porrello A, Jung Y, Yang L, Popov Y, Choi S, et al. Hedgehog signaling regulates epithelialmesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 2008;118:3331-42.
14. Kirby J, Robertson H, Marshall H, Rygiel K, Hudson M, Jones DE, et al. Epithelial to mesenchymal transition in primary sclerosing cholangitis. Liver Int 2008;28:1176-7.
15. Matsumura S, Van De Water J, Leung P, Odin J, Yamamoto K, Gores G, et al. Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology 2004;39:1415-22.
16. Saarinen S, Olerup O, Broomé U. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol 2000;95:3195-9.
17. Bergquist A, Lindberg G, Saarinen S, Broomé U. Increased prevalence of primary sclerosing cholangitis among firstdegree relatives. J Hepatol 2005;42:252-6.
18. Karlsen TH, Schrumpf E, BobergKM. Genetic epidemiology of primary sclerosing cholangitis. WJG 2007;13:5421-31.
19. Snook JA, Chapman RW, Fleming K, Jewell DP. Antineutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1989;76:30-3.
20. Terjung B, Bogsch F, Klein R, Söhne J, Reichel C, Wasmuth JC, et al. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC-and multivariate regression analysis. Eur J Med Res 2004;9:439-48.
21. Ardesjö B, Portela-Gomes GM, Rorsman F, Grimelius L, Ekwall O. Identification of a novel staining pattern of bile duct epithelial cells in primary sclerosing cholangitis. Inflamm Bowel Dis 2010;16:305-11.
22. Schwarze C, Terjung B, Lilienweiss P, Beuers U, Herzog V, Sauerbruch T, et al. IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis. Clin Exp Immunol 2003;133:283-9.
23. Kvale D, Schrumpf E, Brandtzaeg P, Solberg HE, Fausa O, Elgjo K. Circulating secretory immunoglobulins of the A and M isotypes in chronic liver disease. J Hepatol 1987; 4:229-35.
24. Tomita K, Teratani T, Yokoyama H, Suzuki T, Irie R, Ebinuma H, et al. Serum immunoglobulin a concentration is an independent predictor of liver fibrosis in nonalcoholic steatohepatitis before the cirrhotic stage. Dig Dis Sci 2011; 56:3648-54.
25. Hammerschmidt S, Talay SR, Brandtzaeg P, Chhatwal GS. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol Microbiol 1997;25:1113-24.
26. Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NH. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 2000;95:359-67.
27. Hu CJ, Zhang FC, Li YZ, Zhang X. Primary biliary cirrhosis: what do autoantibodies tell us? WJG 2010;16: 3616-29.